COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Yingwen Hu

Yingwen Hu, MDYingwen Hu
Scientist I, Physicochemical Characterization

Dr. Hu joined the Nanotechnology Characterization Laboratory (NCL) as a Scientist in July 2017. Her research focuses on the physicochemical characterization of nanoparticles using advanced analytical methods.

Dr. Hu received her M.D. in Pharmaceutics from the School of Pharmaceutical Sciences at Zhejiang University where her work focused on the development of smart polymer-based nanoparticles for different drug delivery purposes. Prior to joining the NCL, she completed her postdoc training in the Department of Chemistry at Purdue University, developing a human mAb for the treatment of cancer and autoimmune diseases and using nano-sized magnetic beads to capture rare circulating tumor cells.